Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Sensitive Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT06812767
What this trial is testing

Risk Factors at Chronic Non-communicable Diseases in People of Working Age

Who this might be right for
Chronic Non-communicable Disease
National Medical Research Center for Therapy and Preventive Medicine 2,000
Not applicableStudy completedNCT02326376
What this trial is testing

Kineret CAPS Post Authorisation Study

Who this might be right for
Cryopyrin-Associated Periodic Syndromes
Swedish Orphan Biovitrum 12
Not applicableEnrolling By InvitationNCT06848738
What this trial is testing

Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic Ultrasound

Who this might be right for
Lung CancerLymphomaSarcoidosis
Zealand University Hospital 362
Not applicableLooking for participantsNCT05337891
What this trial is testing

Sensitivity of Repetitive Nerve Stimulation Performed in the Evening vs in the Morning in Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Jagiellonian University 40
Not applicableStudy completedNCT04841850
What this trial is testing

Efficiency And Tolerance Of Hazelnut Oral Immunotherapy Protocol In Hazelnut Allergic Children

Who this might be right for
Allergy, NutPediatric ALL
Hospices Civils de Lyon 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT05271318
What this trial is testing

Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.

Who this might be right for
Platinum-refractory Ovarian CarcinomaPlatinum-resistant Ovarian CancerPlatinum-Resistant Fallopian Tube Carcinoma+6 more
TILT Biotherapeutics Ltd. 29
Testing effectiveness (Phase 2)Study completedNCT02793544
What this trial is testing

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

Who this might be right for
Myelodysplastic Syndrome (MDS)Chronic Lymphocytic Leukemia (CLL)Chemotherapy-sensitive Lymphoma+4 more
Center for International Blood and Marrow Transplant Research 80
Not applicableStudy completedNCT02592837
What this trial is testing

EBUS-TBNA vs Flex 19G EBUS-TBNA

Who this might be right for
LymphadenopathyLung CancerSarcoidosis+1 more
Royal Brompton & Harefield NHS Foundation Trust 250
Not applicableStudy completedNCT02689050
What this trial is testing

Optical Biopsy for Thoracic Lymph Nodes.

Who this might be right for
Mediastinal LymphadenopathyNon-small Cell Lung CarcinomaSarcoidosis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 40
Not applicableEnded earlyNCT00721097
What this trial is testing

Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics

Who this might be right for
AsthmaChronic Inflammatory Diseases
Nantes University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01441882
What this trial is testing

Dasatinib in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Refractory Chronic Lymphocytic LeukemiaStage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic Leukemia+2 more
OHSU Knight Cancer Institute 19
Testing effectiveness (Phase 2)WithdrawnNCT02150928
What this trial is testing

An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
Jazz Pharmaceuticals
Not applicableStudy completedNCT02835625
What this trial is testing

The Digital Breast Tomosynthesis Trial in Bergen

Who this might be right for
Breast Neoplasms
Norwegian Institute of Public Health 29,453
Not applicableStudy completedNCT02773095
What this trial is testing

Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative

Who this might be right for
Cardiovascular DiseaseDiabetes Type IIBreast Cancer+1 more
Boston University 966
Testing effectiveness (Phase 2)Study completedNCT02780167
What this trial is testing

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 269
Very early researchNot Yet RecruitingNCT07420036
What this trial is testing

An Open-label, Single-arm, Single-center Study to Evaluate the Diagnostic Efficacy of a Novel PET Probe, 68Ga-SFB6-ZN01, in Patients With Malignant Tumors

Who this might be right for
Neoplasms
Zhongnan Hospital 98
Not applicableNot Yet RecruitingNCT06921278
What this trial is testing

Development of the Drug and Alcohol Respiratory Health Test

Who this might be right for
Respiratory DiseaseSubstance-Related DisordersCOPD+6 more
King's College London 260
Not applicableWithdrawnNCT01467635
What this trial is testing

EBUS-TBNA Versus EBUS-TBNB

Who this might be right for
Mediastinal LymphadenopathyHilar LymphadenopathyCarcinoma+3 more
Royal Brompton & Harefield NHS Foundation Trust
Large-scale testing (Phase 3)Study completedNCT02755597
What this trial is testing

A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy

Who this might be right for
Relapsed/Refractory Multiple Myeloma
AbbVie 291
Testing effectiveness (Phase 2)Study completedNCT00141791
What this trial is testing

Study Evaluating Etanercept in Moderate to Severe Asthma

Who this might be right for
Asthma
Wyeth is now a wholly owned subsidiary of Pfizer 120
Next Page